A Targeting Microbubble for Ultrasound Molecular Imaging

Abstract

RationaleMicrobubbles conjugated with targeting ligands are used as contrast agents for ultrasound molecular imaging. However, they often contain immunogenic (strept)avidin, which impedes application in humans. Although targeting bubbles not employing the biotin-(strept)avidin conjugation chemistry have been explored, only a few reached the stage of ultrasound imaging in vivo, none were reported/evaluated to show all three of the following properties desired for clinical applications: (i) low degree of non-specific bubble retention in more than one non-reticuloendothelial tissue; (ii) effective for real-time imaging; and (iii) effective for acoustic quantification of molecular targets to a high degree of quantification. Furthermore, disclosures of the compositions and methodologies enabling reproduction of the bubbles are often withheld.ObjectiveTo develop and evaluate a targeting microbubble based on maleimide-thiol conjugation chemistry for ultrasound molecular imaging.Methods and ResultsMicrobubbles with a previously unreported generic (non-targeting components) composition were grafted with anti-E-selectin F(ab’)2 using maleimide-thiol conjugation, to produce E-selectin targeting microbubbles. The resulting targeting bubbles showed high specificity to E-selectin in vitro and in vivo. Non-specific bubble retention was minimal in at least three non-reticuloendothelial tissues with inflammation (mouse heart, kidneys, cremaster). The bubbles were effective for real-time ultrasound imaging of E-selectin expression in the inflamed mouse heart and kidneys, using a clinical ultrasound scanner. The acoustic signal intensity of the targeted bubbles retained in the heart correlated strongly with the level of E-selectin expression (|r|≥0.8), demonstrating a high degree of non-invasive molecular quantification.ConclusionsTargeting microbubbles for ultrasound molecular imaging, based on maleimide-thiol conjugation chemistry and the generic composition described, may possess properties (i)–(iii) desired for clinical applications.

New Ultrasound Techniques Promise Further Advances in AKI and CKD

“…37 There is clear evidence that coupling US imaging with MB targeted to inflammatory markers is a promising means to detect changes in the renal vasculature that are indicative of AKI. 37,41 In a study by our laboratory, rats subjected to 30 minutes of bilateral IRI or sham controls were assessed by US coupled with mAblabeled MBs targeted to P-selectin or VCAM-1 4 and 24 hours after injury. Relative to control animals, there was significant signal enhancement at 4 hours in injured animals, with subsequent signal diminution at 24 hours.…”

Nano Meets Micro-Translational Nanotechnology in Medicine: Nano-Based Applications for Early Tumor Detection and Therapy

“…Molecular imaging can be performed with MBs containing targeting ligands on the bubble-shell. During systemic circulation, targeted MBs progressively accumulate in the regions expressing the targeted molecules, defining areas of bright signals on UlS pictures [100,101]. As a consequence, the use of microbubbles for UlS-imaging can enhance their quality by precisely defining the region of targeted MBs accumulation.…”

Development of Antibody-Modified Nanobubbles Using Fc-Region-Binding Polypeptides for Ultrasound Imaging

“…Microbubbles aid in enhancing the specificity and sensitivity of US imaging and can be applied for various types of diseases, particularly tumors [5,6]. For this purpose, targeting strategies for microbubbles have been demonstrated [7,8,9,10,11]. Among these targeting strategies, antibodies have been used as a targeting moiety of microbubbles, and the avidin–biotin interaction has often been adopted to modify microbubbles with antibodies.…”